Clinical trials: Moxifloxacin
Cardiovascular Abnormalities
Evaluation of the Cardiac Effects of a Novel Food Ingredient in Healthy Male Subjects
This study evaluates if a single oral dose of 150 mg of the novel food ingredient (AME001, R,R-monatin) does not have an effect on the Fridericia-corrected QT ECG interval (QTcF) exceeding 10 milliseconds (msec).
- Trial name
- NCT02616913
- Testing
- R,R-monatin, Moxifloxacin
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- Cargill
Normal Healthy Subjects
A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization
This is a randomized, placebo- and positive-controlled (moxifloxacin), 3-period, 3-way crossover thorough QT study, which includes a Screening Period, Treatment Periods (1 through 3), and a Follow-up Visit.
- Trial name
- NCT01941446
- Volunteers
- 54 people, healthy volunteers welcome
- Sponsor
- Tetraphase Pharmaceuticals, Inc
Long QT Syndrome
Effect of Grapefruit on QT Interval in Healthy Volunteers and Patients With Congenital Long QT Syndrome
The list of medications that prolong the QT interval and can provoke torsade de pointes keeps expanding. This list includes not only antiarrhythmic drugs, but also medications with no cardiac indications.
- Trial name
- NCT02680080
- Testing
- Moxifloxacin, Grapefruit group
- Where
- Israel
- Volunteers
- 25 people, healthy volunteers welcome
- Sponsor
- Tel-Aviv Sourasky Medical Center
Infection
Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem
A study to compare the safety and efficacy of moxifloxacin to ertapenem in patients with intra-abdominal infections.
- Trial name
- NCT00492726
- Testing
- Moxifloxacin (Avelox, BAY12-8039), Ertapenem intravenous
- Where
- 52 sites in Argentina, Belgium and 12 more
- Volunteers
- 804 people
- Sponsor
- Bayer